Different Effects of Resveratrol on Dose-Related Doxorubicin-Induced Heart and Liver Toxicity

The aim of the study was to evaluate the effect of resveratrol in doxorubicin-induced cardiac and hepatic toxicity. Doxorubicin was administered once a week throughout the period of 7 weeks with 1.0 or 2.0 mg/kg body weight or concomitantly with resveratrol (20 mg/kg of feed). Heart and liver toxici...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Dudka, Jaroslaw, Gieroba, Renata, Korga, Agnieszka, Burdan, Franciszek, Matysiak, Wlodzimierz, Jodlowska-Jedrych, Barbara, Mandziuk, Slawomir, Korobowicz, Elzbieta, Murias, Marek
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2012
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3522488/
https://ncbi.nlm.nih.gov/pubmed/23258992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/606183
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares